SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008549
Filing Date
2022-05-12
Accepted
2022-05-12 16:16:26
Documents
66
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q agrx-20220331x10q.htm   iXBRL 10-Q 1162131
2 EX-10.5 agrx-20220331xex10d5.htm EX-10.5 148651
3 EX-31.1 agrx-20220331xex31d1.htm EX-31.1 10619
4 EX-31.2 agrx-20220331xex31d2.htm EX-31.2 10561
5 EX-32.1 agrx-20220331xex32d1.htm EX-32.1 5934
6 EX-32.2 agrx-20220331xex32d2.htm EX-32.2 5901
  Complete submission text file 0001558370-22-008549.txt   5526797

Data Files

Seq Description Document Type Size
7 EX-101.SCH agrx-20220331.xsd EX-101.SCH 45366
8 EX-101.CAL agrx-20220331_cal.xml EX-101.CAL 43578
9 EX-101.DEF agrx-20220331_def.xml EX-101.DEF 191932
10 EX-101.LAB agrx-20220331_lab.xml EX-101.LAB 400473
11 EX-101.PRE agrx-20220331_pre.xml EX-101.PRE 304009
60 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20220331x10q_htm.xml XML 701773
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36464 | Film No.: 22918018
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences